Back

Results - Announcements

Sales rise 15.37% to Rs 38.29 crore

Bafna Pharmaceuticals standalone net profit rises 93.68% in the December 2025 quarter

12-Feb-2026, 07:46
Net profit of Bafna Pharmaceuticals rose 93.68% to Rs 1.84 crore in the quarter ended December 2025 as against Rs 0.95 crore during the previous quarter ended December 2024. Sales rose 15.37% to Rs 38.29 crore in the quarter ended December 2025 as against Rs 33.19 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	38.29	33.19	15
OPM %	7.97	9.25	-
PBDT	3.41	2.62	30
PBT	1.84	0.96	92
NP	1.84	0.95	94